VECTUS BIOSYSTEMS LIMITED
ASX:VBSPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 98.9% of what they think they own, once every option and right converts.
Runway 2–4 quarters; share count grew 17% in 24 months; 1 cash raise in 24 months
Between October 2024 and September 2026, its latest share-count filing, VECTUS BIOSYSTEMS LIMITED ordinary share count grew 16.8% to 62M shares. The company made one capital raise in the past 24 months, a Placement in May 2026 for total proceeds of A$791K. Options and rights on issue could convert into 663,116 new shares, equal to 1.1% of the current share count, with none currently in the money and the nearest expiry in May 2028. Cash funding stands at 2 to 4 quarters of funding at the recent spend rate. No proposed securities issues are pending.
Quick answers · 5
When did VBS last raise capital?
The last capital raise in Vectus Biosystems's filings is Placement of $791k announced 22 May 2026, one of 1 cash raises in 24 months.
How much placement capacity does VBS have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does VBS have?
In its quarterly cash report for the quarter ended 30 June 2026, Vectus Biosystems reported $718k of cash and estimated 4.3 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do VBS's options expire?
Unexercised options and rights equal 1.1% of Vectus Biosystems's shares on issue; the nearest expiry is May 2028.
How much has VBS's share count grown?
Vectus Biosystems has 62.2M shares on issue as at 28 Oct 2026, up 16.8% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 2 Sept 2026 | 2A · quoted issue | VBS : ORDINARY FULLY PAID | 62.2M | Appendix 2A |
| 29 July 2026 | 2A · quoted issue | VBS : ORDINARY FULLY PAID | 61.9M | Appendix 2A |
| 26 June 2026 | 2A · quoted issue | VBS : ORDINARY FULLY PAID | 61.7M | Appendix 2A |
| 27 May 2026 | 2A · quoted issue | VBS : ORDINARY FULLY PAID | 61.5M | Appendix 2A |
| 12 May 2026 | 2A · quoted issue | VBS : ORDINARY FULLY PAID | 53.6M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 663k of it states a NIL exercise price: nothing is paid to convert it, so it converts at any price rather than on a hurdle.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| VBSAL | Options | Price-triggered | Nil | 7 May 2028 | 42k | Filing |
| VBSAO | Options | Price-triggered | Nil | 7 May 2030 | 621k | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
- VBSAHPrice-triggered316k securities → 02 Sept 2026 Appendix 2A
- VBSAJPrice-triggered13k securities → 029 July 2026 Appendix 2A
- VBSAMPrice-triggered25k securities → 023 Dec 2025 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 2 Sept 2026 | Maurie Stang | Other incentive | 316k | 316k | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.